Researchers evaluated the virologic and immunologic characteristics of a patient with previously confirmed HIV infection who had an undetectable HIV viral load for more than 7 years after discontinuing antiretroviral therapy.
Investigators conducted a study to assess the rates of high-risk sexual behavior and sexually transmitted infections among men who have sex with men before and after the introduction of HIV pre-exposure prophylaxis.
Researchers conducted a study to determine whether patients with untreated HIV infection have consistently decreased cerebrospinal fluid HIV RNA viral loads vs plasma HIV RNA throughout various stages of the disease.
Investigators assessed the relationship between HIV infection and impaired pulmonary gas exchange, as well as the influence HIV has on the diffusing capacity of the lungs for carbon monoxide in patients with and without comorbid chronic obstructive pulmonary disease.
Researchers conducted a study that compared virologic suppression, lipid control, and safety profiles of patients with HIV infection who switch from ritonavir-boosted darunavir to doravirine (DOR) therapy vs those who continued DOR therapy.
Researchers conducted a study that included patients with HIV infection who previously achieved virologic suppression to compare the risk for virologic failure among those who switch to a single-tablet 2-drug regimen vs those who switch to a single-tablet 3-drug regimen.
Investigators conducted a study that compared the rate of persistence and re-initiation of HIV pre-exposure prophylaxis among patients treated with emtricitabine/tenofovir alafenamide vs those treated with emtricitabine/tenofovir disoproxil fumarate.